Scarica l'app Stockscreener
2.21
3.76%
0.08
Dopo l'orario di chiusura:
2.27
0.06
+2.71%
Precedente Chiudi:
$2.13
Aprire:
$2.15
Volume 24 ore:
157.87K
Relative Volume:
1.54
Capitalizzazione di mercato:
$14.73M
Reddito:
$1.03M
Utile/perdita netta:
$-10.89M
Rapporto P/E:
-0.3921
EPS:
-5.6364
Flusso di cassa netto:
$-9.89M
1 W Prestazione:
+17.55%
1M Prestazione:
+45.39%
6M Prestazione:
-12.30%
1 anno Prestazione:
-46.23%
Intervallo 1D:
$2.12
$2.2956
Intervallo di 1 settimana:
$1.89
$2.39
Portata 52W:
$1.40
$4.6399
Sintx Technologies Inc Stock (SINT) Company Profile
Nome
Sintx Technologies Inc
Settore
Industria
Telefono
801-839-3516
Indirizzo
1885 WEST 2100 STREET, SALT LAKE CITY, UT
Compare SINT vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SINT
Sintx Technologies Inc
|
2.21 | 12.53M | 1.03M | -10.89M | -9.89M | -5.6364 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sintx Technologies Inc Stock (SINT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-13 | Iniziato | H.C. Wainwright | Buy |
| 2019-09-12 | Iniziato | Ascendiant Capital Markets | Buy |
Sintx Technologies Inc Borsa (SINT) Ultime notizie
SINTX Announces Preliminary $2.2 Million Q3 Revenue Above Guidance - Quiver Quantitative
SINTX reports preliminary $2.2M Q3 revenue, exceeds guidance and triggers call right on Class B warrants - TradingView
SINTX reports Q3 revenue of $2.2M, up 380% from prior quarter - Investing.com
Sintx Technologies Reports Surging Preliminary Third-Quarter Revenue - TipRanks
Ceramics maker SINTX Technologies Q3 revenue jumps on industrial sales - TradingView
SiNtx Technologies Is Maintained at Buy by Ascendiant Capital - Moomoo
SINTX sponsors educational program on silicon nitride implants - Investing.com
SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics Experts - The Manila Times
Three experts examine a material for orthopedic implants. SINTX sponsors the class. - Stock Titan
SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference - marketscreener.com
An implant system cleared by the FDA will be highlighted in New York by SINTX - Stock Titan
SINT Q2 2026 Earnings: Wider-Than-Expected $0.75 Per-Share Loss Meets Modest 1.95% Share GainNew Analyst Coverage - dars.gov.et
SINTX TECHNOLOGIES (SINT) Moves to Buy: Rationale Behind the Upgrade - Eastern Progress
SiNtx (SINT) Earnings Reading: Profit Per Share Falls Below Its Benchmark in the Available Record; Share Move: The Stock Loses 5.03% on the DayRetail Earnings Report - vinanet.vn
Sintx Technologies, Inc. SEC Filing (Aug 19, 2026) - Stock Titan
Bleichroeder discloses 9.99% SINTX Technologies (SINT) stake with warrant limits - Stock Titan
SINTX regains Nasdaq compliance with stockholders’ equity - Investing.com
Form 8K SINTX Technologies Inc For: 13 August By Investing.com - Investing.com South Africa
SINTX regains Nasdaq compliance with stockholders’ equity By Investing.com - Investing.com Australia
SINTX Regains Nasdaq Compliance, Supporting Growth Initiatives - TipRanks
SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement - The Manila Times
Sintx Technologies Regains Nasdaq Equity Compliance After Reporting $4.83M in Stockholders' Equity - TradingView
H.C. Wainwright reiterates Buy on SINTX Tech stock, $10 target - investing.com
H.C. Wainwright reiterates Buy on SINTX Tech stock, $10 target By Investing.com - Investing.com Canada
SiNtx Technologies (SINT) Slides 11.3% as Selling Pressure Intensifies Toward Key SupportStrong Buy Stocks - Vinanet
H.C. Wainwright Maintains Sintx Technologies(SINT.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Sintx Technologies, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Sintx Technologies Q2 2026 Earnings Call Transcript - MarketBeat
SINTX Technologies earnings missed by $0.08, revenue topped estimates - Investing.com Canada
SINTX Technologies Inc (SINT) (Q2 2026) Earnings Call Highlights - GuruFocus
SINTX Technologies Inc (SINT) (Q2 2026) Earnings Call Highlights: Revenue Surges 199% as ... By GuruFocus - Investing.com Canada
SINTX Technologies Inc (SINT) (Q2 2026) Earnings Call Highlights: Revenue Surges 199% as ... - finance.yahoo.com
SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives - Technology Magazine
SINT Looks 1080.0% Overvalued on GF Value™ - GuruFocus
SINTX Technologies Q2 Results: Revenue guidance set at $900K-$1.1M for Q3 - scanx.trade
Earnings call transcript: SINTX posts Q2 2026 revenue growth but shares slip after hours - Investing.com Australia
SINTX Technologies Q2 Results: Sales Surge 199% YoY, EPS Misses - scanx.trade
SINTX projects Q3 revenue of $900,000 to $1.1 million By Investing.com - Investing.com South Africa
SINT: Revenue up 199% year-over-year, but liquidity risk persists amid commercialization efforts - TradingView
Transcript : Sintx Technologies, Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
SINTX TECHNOLOGIES ($SINT) Releases Q2 2026 Earnings - Quiver Quantitative
Form 8K SINTX Technologies Inc For: 11 August By Investing.com - Investing.com Nigeria
Sintx Technologies Advances Commercialization and Strengthens Financial Position - TipRanks
SINTX projects Q3 revenue of $900,000 to $1.1 million - Investing.com
SINT: Q2 2026 revenue surged 199% year-over-year, but net loss increased and liquidity risks persist - TradingView
SINTX Technologies (NASDAQ: SINT) flags going-concern risk amid losses - Stock Titan
Sintx Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Trending Stocks Today | Dermata Therapeutics Soars 35.18% Post-Market - Moomoo
SINT Q1 2026 Earnings: EPS Misses Estimates by 3.98%, Shares Still Climb 6.02%Gross Profit Margin - vinanet.vn
SINTX Technologies Inc (SINT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SINTX Technologies Inc expected to post a loss of 67 cents a shareEarnings Preview - TradingView
Sintx Technologies Inc Azioni (SINT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sintx Technologies Inc Azioni (SINT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lyons Christopher Michael | Director |
Feb 25 '26 |
Buy |
2.96 |
758 |
2,244 |
758 |
| MOYES JAY M | Director |
Feb 23 '26 |
Buy |
2.91 |
1,000 |
2,910 |
4,000 |
| Anderson Mark Lewis | Director |
Feb 18 '26 |
Buy |
3.02 |
3,000 |
9,060 |
18,000 |
| Honigblum Gregg R. | Chief Investment Officer |
Dec 08 '25 |
Buy |
4.26 |
8,200 |
34,896 |
201,067 |
| Honigblum Gregg R. | Chief Investment Officer |
Dec 05 '25 |
Buy |
3.93 |
65,000 |
255,350 |
139,000 |
| Honigblum Gregg R. | Chief Investment Officer |
Nov 07 '25 |
Buy |
3.19 |
10,000 |
31,900 |
74,000 |
| Olson Eric K. | President and CEO |
Oct 20 '25 |
Buy |
3.40 |
5,800 |
19,720 |
30,775 |
0.26%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):